R51163, a newly synthesized purine alkyl piperidine that produces reliable sedation in cattle, was tested in five adult bull moose (Alces alces) Compared with controls, all animals dosed with 0.4 mg/kg BW ate significantly (P < 0.05) less dry matter for at least 1 wk after treatment. Median estimates of resting metabolism, measured the day of injection. did not differ between treatment and control groups, although the coefficient of variation was almost two times larger for drugged (15%) versus control (8%) individuals. Dose response was allometric, with larger animals exhibiting longer effects.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.